204 related articles for article (PubMed ID: 33052945)
1. Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.
Okuda M; Fujita Y; Takada-Takatori Y; Sugimoto H; Urakami K
PLoS One; 2020; 15(10):e0240378. PubMed ID: 33052945
[TBL] [Abstract][Full Text] [Related]
2. Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase.
Liu B; Kou J; Li F; Huo D; Xu J; Zhou X; Meng D; Ghulam M; Artyom B; Gao X; Ma N; Han D
Aging (Albany NY); 2020 May; 12(9):8622-8639. PubMed ID: 32392535
[TBL] [Abstract][Full Text] [Related]
3. SuHeXiang Wan essential oil alleviates amyloid beta induced memory impairment through inhibition of tau protein phosphorylation in mice.
Jeon S; Hur J; Jeong HJ; Koo BS; Pak SC
Am J Chin Med; 2011; 39(5):917-32. PubMed ID: 21905282
[TBL] [Abstract][Full Text] [Related]
4. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.
Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T
J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610
[TBL] [Abstract][Full Text] [Related]
6. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
7. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
9. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
11. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
Huber CM; Yee C; May T; Dhanala A; Mitchell CS
J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
[TBL] [Abstract][Full Text] [Related]
13. PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.
Okuda M; Fujita Y; Hijikuro I; Wada M; Uemura T; Kobayashi Y; Waku T; Tanaka N; Nishimoto T; Izumi Y; Kume T; Akaike A; Takahashi T; Sugimoto H
J Alzheimers Dis; 2017; 59(1):313-328. PubMed ID: 28598836
[TBL] [Abstract][Full Text] [Related]
14. Sedative and hypnotic effects of compound Anshen essential oil inhalation for insomnia.
Zhong Y; Zheng Q; Hu P; Huang X; Yang M; Ren G; Du Q; Luo J; Zhang K; Li J; Wu H; Guo Y; Liu S
BMC Complement Altern Med; 2019 Nov; 19(1):306. PubMed ID: 31711477
[TBL] [Abstract][Full Text] [Related]
15. Effect of aromatherapy on patients with Alzheimer's disease.
Jimbo D; Kimura Y; Taniguchi M; Inoue M; Urakami K
Psychogeriatrics; 2009 Dec; 9(4):173-9. PubMed ID: 20377818
[TBL] [Abstract][Full Text] [Related]
16. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
17. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
18. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.
Michalski B; Corrada MM; Kawas CH; Fahnestock M
Neurobiol Aging; 2015 Dec; 36(12):3130-3139. PubMed ID: 26410307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
